CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

BACKGROUND: Cyclin D1 (CCND1) has been associated with chemotherapy resistance and poor prognosis. In this study, we tested the hypothesis that CCND1 expression determines response and clinical outcomes in locally advanced head and neck squamous cell carcinoma (HNSCC) patients treated with neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhien, Guo, Wei, Zhang, Chenping, Xu, Qin, Zhang, Ping, Sun, Jian, Zhu, Hanguang, Wang, Zhonghe, Li, Jiang, Wang, Lizhen, Wang, Bingshun, Ren, Guoxin, Ji, Tong, Tu, Wenyong, Yang, Xihu, Qiu, Weiliu, Mao, Li, Zhang, Zhiyuan, Chen, Wantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204964/
https://www.ncbi.nlm.nih.gov/pubmed/22065993
http://dx.doi.org/10.1371/journal.pone.0026399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204964/
https://www.ncbi.nlm.nih.gov/pubmed/22065993
http://dx.doi.org/10.1371/journal.pone.0026399

Ejemplares similares